
Steth Pharmaceuticals LLP
About Steth Pharmaceuticals LLP
Data last updated:
Steth Pharmaceuticals LLP is a limited liability partnership (LLP) based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 March 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Bangalore, under LLPIN AAG-0212. Its GSTIN is 29ADAFS5372C1Z3 (Karnataka).
The LLP has a total obligation of contribution of βΉ1 Lakh. It is led by designated partners Jayashree and Rajesh Kodanda Ramu.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo.2397/15 18th Main, Kumaraswamy Layout 2nd Stage, Bangalore, Karnataka, India β 560078
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Steth Pharmaceuticals LLP FY 2025 filings available
Financial Statement Summary of Steth Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Steth Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Steth Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Steth Pharmaceuticals LLP
Steth Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayashree | Designated Partner | 22 Mar 2016 | 10 Years 6 Months | Current |
| Rajesh Kodanda Ramu Also directs: Steth Biomed Solutions LLP | Designated Partner | 22 Mar 2016 | 10 Years 6 Months | Current |
Charges & Borrowings of Steth Pharmaceuticals LLP
Steth Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Steth Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Steth Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Steth Pharmaceuticals LLP
Steth Pharmaceuticals LLP has 2 designated partner changes on record since 2016: 2 appointments. The latest: Jayashree was appointed as Designated Partner on 22 Mar 2016.
Credit Ratings, Litigation & Regulatory Alerts for Steth Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Steth Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Steth Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Steth Pharmaceuticals LLP
Steth Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29ADAFS5372C1Z3 | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Steth Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Steth Pharmaceuticals LLP
Steth Pharmaceuticals is an active limited liability partnership based in Bangalore, Karnataka, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 22 March 2016 (10+ years old) and is registered under LLPIN AAG-0212.
Steth Pharmaceuticals has 2 current designated partners:
- Jayashree - Designated Partner
- Rajesh Kodanda Ramu - Designated Partner
The GSTIN of Steth Pharmaceuticals is 29ADAFS5372C1Z3, registered in Karnataka.
The LLPIN (Limited Liability Partnership Identification Number) of Steth Pharmaceuticals is AAG-0212. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Steth Pharmaceuticals was incorporated on 22 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
Jayashree was appointed as Designated Partner on 22 Mar 2016. Rajesh Kodanda Ramu was appointed as Designated Partner on 22 Mar 2016.
The registered office of Steth Pharmaceuticals is at No.239715 18th Main, Kumaraswamy Layout 2nd Stage, Bangalore, Karnataka, India β 560078.
The total obligation of contribution is βΉ1 Lakh.
Steth Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Steth Pharmaceuticals can be reached at its registered office: No.239715 18th Main, Kumaraswamy Layout 2nd Stage, Bangalore, Karnataka, India β 560078.